| 注册
首页|期刊导航|肿瘤学与转化医学(英文)|FGF2 promotes the chemotherapy resistance in colon cancer cells through activating PI3K/Akt signaling pathway

FGF2 promotes the chemotherapy resistance in colon cancer cells through activating PI3K/Akt signaling pathway

Xiao-Lan Jian Pu-Hua Zeng Ke-Xiong Li Wei Peng

肿瘤学与转化医学(英文)2023,Vol.9Issue(6):281-286,6.
肿瘤学与转化医学(英文)2023,Vol.9Issue(6):281-286,6.DOI:10.1097/ot9.0000000000000018

FGF2 promotes the chemotherapy resistance in colon cancer cells through activating PI3K/Akt signaling pathway

FGF2 promotes the chemotherapy resistance in colon cancer cells through activating PI3K/Akt signaling pathway

Xiao-Lan Jian 1Pu-Hua Zeng 1Ke-Xiong Li 1Wei Peng1

作者信息

  • 1. Hunan Academy of Traditional Chinese Medicine Affiliated Hospital,Changsha,Hunan,China
  • 折叠

摘要

关键词

Chemotherapy drug resistance/Colorectal cancer/Fibroblast growth factor/PI3K/Akt signaling pathway

Key words

Chemotherapy drug resistance/Colorectal cancer/Fibroblast growth factor/PI3K/Akt signaling pathway

引用本文复制引用

Xiao-Lan Jian,Pu-Hua Zeng,Ke-Xiong Li,Wei Peng..FGF2 promotes the chemotherapy resistance in colon cancer cells through activating PI3K/Akt signaling pathway[J].肿瘤学与转化医学(英文),2023,9(6):281-286,6.

基金项目

The study was supported by the National Natural Science Foundation of China(no.81904109)and the Natural Science Project of Hunan Provincial Department of Science and Technology(no.2023JJ30361,no.2019JJ50344). (no.81904109)

肿瘤学与转化医学(英文)

OACSTPCD

2095-9621

访问量0
|
下载量0
段落导航相关论文